October 23, 2016 12:20 PM ET


Company Overview of Loxo Oncology, Inc.

Executive Profile

Joshua H. Bilenker M.D.

Founder, Chief Executive Officer, President and Director, Loxo Oncology, Inc.
AgeTotal Calculated CompensationThis person is connected to 7 Board Members in 7 different organizations across 8 different industries.

See Board Relationships
As of Fiscal Year 2015


Dr. Joshua H. Bilenker, also known as Josh, MD, serves as an Operating Partner at Aisling Capital LLC since November 2013. Dr. Bilenker has been the Chief Executive Officer and President at Loxo Oncology, Inc., since June 2013, which he founded in May 2013. Dr. Bilenker joined Aisling Capital LLC in April 2006. He previously served as a Principal at the firm. Dr. Bilenker served as the Chief Financial Officer and Principal Accounting Officer at Loxo Oncology, Inc. Prior ...

Corporate Headquarters

281 Tresser Boulevard
Stamford, Connecticut 06901

United States

Phone: 203-653-3880
Fax: --

Board Members Memberships

Director and Chairman of Nominating & Corporate Governance Committee
Founder, Chief Executive Officer, President and Director
Director and Member of Compensation Committee


Johns Hopkins School of Medicine
Princeton University

Other Affiliations

Annual Compensation

Total Annual Compensation$413,800

Stocks Options

Exercisable Options$445,040
Unexercisable Options$444,404
Total Number of Options$889,444

Total Compensation

Total Annual Cash Compensation$662,080
Total Short Term Compensation$413,800
Total Calculated Compensation$3,645,876

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Loxo Oncology, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.